Brief: Xbiotech Discovers Covid-19 Candidate Therapy
17/08/2020 16:18
XBiotech Inc XBIT.O :
* XBIOTECH DISCOVERS COVID-19 CANDIDATE THERAPY
* XBIOTECH INC - IDENTIFIED TRUE HUMAN ANTIBODIES THAT COULD
POTENTIALLY BE USED AS A THERAPY AGAINST SARS-COV2
Source text for Eikon: ID:nGNX2ZljWY
Further company coverage: XBIT.O
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke